Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB is a generic product labeled by Solco Healthcare US LLC, priced at $1.0569 per EA under NDC 43547046009. Its NADAC has been published 156 times since Jul 5, 2023.
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB
candesartan cilexetil and hydrochlorothiazideStrength
32; 12.5 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547046009
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207455On Market Since
11/20/2017
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has been published 156 times since Jul 5, 2023, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0569 per EA |
|---|---|
| All-time high | $1.7884 (Dec 13, 2023) |
| All-time low | $0.7888 (Nov 20, 2024) |
| 52-week high | $1.2226 |
| 52-week low | $1.0214 |
| Median price | $1.1739 |
| Average price | $1.2311 |
| Largest weekly change | -41.2% (Nov 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB, manufactured by Solco Healthcare US LLC, is $1.0569 per EA (NDC 43547046009), effective Jun 24, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has declined 38.4%. It has been tracked across 156 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
Since Jul 5, 2023, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has ranged from a low of $0.7888 (Nov 20, 2024) to a high of $1.7884 (Dec 13, 2023), with a median of $1.1739 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB (NDC 43547046009) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification